Viking Therapeutics (VKTX) Misses Q4 EPS by 3c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• Accenture downgraded by TD Cowen on AI concerns